News

Week Low Stocks to Buy Right Now. On June 26, Merck & Co., Inc. (NYSE:MRK) announced that the Advisory Committee on Immunization Practices has approved ENFLONSIA for preventing respiratory syncytial ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
Immunizations “are not all good or bad,” says the chair of the overhauled panel.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...
U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
Although the U.S. CDC’s Advisory Committee for Immunization Practices (ACIP) was scheduled to vote June 25 on recommendations ...